Toll Free: 1-888-928-9744
Published: Feb, 2016 | Pages:
186 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Diarrhea - Pipeline Review, H1 2016 Summary
Global Markets Direct's, 'Diarrhea - Pipeline Review, H1 2016', provides an overview of the Diarrhea pipeline landscape. The report provides comprehensive information on the therapeutics under development for Diarrhea, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Diarrhea and features dormant and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data. Scope - The report provides a snapshot of the global therapeutic landscape of Diarrhea - The report reviews pipeline therapeutics for Diarrhea by companies and universities/research institutes based on information derived from company and industry-specific sources - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved Diarrhea therapeutics and enlists all their major and minor projects - The report assesses Diarrhea therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report summarizes all the dormant and discontinued pipeline projects - The report reviews latest news related to pipeline therapeutics for Diarrhea Reasons to buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Diarrhea - Identify potential new clients or partners in the target demographic - Develop strategic initiatives by understanding the focus areas of leading companies - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Diarrhea pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Table of Contents
Table of Contents 2 List of Tables 5 List of Figures 6 Introduction 7 Global Markets Direct Report Coverage 7 Diarrhea Overview 8 Therapeutics Development 9 Pipeline Products for Diarrhea - Overview 9 Pipeline Products for Diarrhea - Comparative Analysis 10 Diarrhea - Therapeutics under Development by Companies 11 Diarrhea - Therapeutics under Investigation by Universities/Institutes 14 Diarrhea - Pipeline Products Glance 15 Late Stage Products 15 Clinical Stage Products 16 Early Stage Products 17 Diarrhea - Products under Development by Companies 18 Diarrhea - Products under Investigation by Universities/Institutes 21 Diarrhea - Companies Involved in Therapeutics Development 22 A. Menarini Industrie Farmaceutiche Riunite Srl 22 Ache Laboratorios Farmaceuticos S/A 23 Actelion Ltd 24 Aegis Therapeutics, LLC 25 Akthelia Pharmaceuticals Limited 26 AlbireoPharma 27 Allergan Plc 28 Anatara Lifesciences Limited 29 Ardelyx, Inc. 30 Assembly Biosciences, Inc. 31 Chiesi Farmaceutici SpA 32 Cosmo Pharmaceuticals S.p.A 33 DesignMedix, Inc. 34 DiscoveryBiomed, Inc. 35 Genexine, Inc. 36 GlaxoSmithKline Plc 37 GP Pharm, S.A. 38 Helsinn Healthcare S.A. 39 Intercept Pharmaceuticals, Inc. 40 Merck & Co., Inc. 41 Mucosis B.V. 42 Nippon Shinyaku Co., Ltd. 43 Novartis AG 44 Pfizer Inc. 45 Prokarium Limited 46 Protagonist Therapeutics Inc. 47 Rebiotix Inc. 48 RxBio, Inc. 49 Sanofi Pasteur SA 50 Scandinavian Biopharma Holding AB 51 Shire Plc 52 Sigmoid Pharma Limited 53 Summit Therapeutics Plc 54 Synthetic Biologics, Inc. 55 Syntiron LLC 56 Diarrhea - Therapeutics Assessment 57 Assessment by Monotherapy Products 57 Assessment by Target 58 Assessment by Mechanism of Action 60 Assessment by Route of Administration 62 Assessment by Molecule Type 64 Drug Profiles 66 ABM-101 - Drug Profile 66 ACE-527 - Drug Profile 67 ACE-920 - Drug Profile 69 ACH-04 - Drug Profile 70 AKT-10081 - Drug Profile 71 ASP-7147 - Drug Profile 72 cadazolid - Drug Profile 73 Campylobacter jejuni [strain CPS81-176] vaccine - Drug Profile 74 cholestyramine - Drug Profile 76 Clostridium difficile vaccine - Drug Profile 77 crofelemer DR - Drug Profile 78 Drug for Diarrhea - Drug Profile 80 elsiglutide - Drug Profile 81 eluxadoline - Drug Profile 82 Escherichia coli vaccine - Drug Profile 84 ETEC vaccine - Drug Profile 85 ETEC vaccine - Drug Profile 86 Etvax - Drug Profile 87 fidaxomicin - Drug Profile 89 GVXNSD-133 - Drug Profile 93 GXG-8 - Drug Profile 94 Helicobacter pylori [strain Hel-305] (multivalent) vaccine - Drug Profile 95 ibodutant - Drug Profile 96 IMSUTMR-1501 - Drug Profile 97 infectious diarrhea [serotype H11] vaccine - Drug Profile 98 obeticholic acid - Drug Profile 99 octreotide acetate - Drug Profile 102 octreotide acetate MAR - Drug Profile 103 Peptide to Activate NHE-3 for Diarrhea - Drug Profile 104 PF-06425090 - Drug Profile 105 prulifloxacin - Drug Profile 106 PZ-7475 - Drug Profile 108 RBX-2660 - Drug Profile 109 RDX-009 - Drug Profile 111 Recombinant Peptide to Activate Mucin 3 for Enterocolitis and Infectious Diarrhea - Drug Profile 112 Recombinant Proteins for Infectious Diarrhea - Drug Profile 114 ridinilazole - Drug Profile 115 rifamycin CR - Drug Profile 117 Rx-100 - Drug Profile 119 Small Molecule to Block CFTR for Diarrhoea - Drug Profile 121 Small Molecule to Inhibit EnaC and CFTR for Cystic Fibrosis, Diarrhea and Autosomal Dominant Polycystic Kidney Disease - Drug Profile 122 Small Molecules for Microbial Infections - Drug Profile 123 Small Molecules to Inhibit Beta-Glucuronidase for Chemotherapy Induced Diarrhea - Drug Profile 124 Small Molecules to Inhibit CFTR for Secretory Diarrhea - Drug Profile 125 surotomycin - Drug Profile 126 SYN-004 - Drug Profile 127 Synthetic Peptide for Irritable Bowel Syndrome with Diarrhea - Drug Profile 128 Typhetec - Drug Profile 129 Vaccine 1 for Diarrhea - Drug Profile 130 Vaccine 2 for Diarrhea - Drug Profile 131 Vaccine for Traveler's Diarrhea - Drug Profile 132 Vaccine to Target Capsular Vi Polysaccharide Antigen for Traveler's Diarrhea - Drug Profile 133 VP-20621 - Drug Profile 134 Yersinia pestis vaccine - Drug Profile 135 Diarrhea - Recent Pipeline Updates 136 Diarrhea - Dormant Projects 171 Diarrhea - Discontinued Products 174 Diarrhea - Product Development Milestones 175 Featured News & Press Releases 175 Appendix 181 Methodology 181 Coverage 181 Secondary Research 181 Primary Research 181 Expert Panel Validation 181 Contact Us 181 Disclaimer 182
List of Tables
Number of Products under Development for Diarrhea, H1 2016 13 Number of Products under Development for Diarrhea - Comparative Analysis, H1 2016 14 Number of Products under Development by Companies, H1 2016 15 Number of Products under Development by Companies, H1 2016 (Contd..1) 16 Number of Products under Development by Companies, H1 2016 (Contd..2) 17 Number of Products under Investigation by Universities/Institutes, H1 2016 18 Comparative Analysis by Late Stage Development, H1 2016 19 Comparative Analysis by Clinical Stage Development, H1 2016 20 Comparative Analysis by Early Stage Development, H1 2016 21 Products under Development by Companies, H1 2016 22 Products under Development by Companies, H1 2016 (Contd..1) 23 Products under Development by Companies, H1 2016 (Contd..2) 24 Products under Investigation by Universities/Institutes, H1 2016 25 Diarrhea - Pipeline by A. Menarini Industrie Farmaceutiche Riunite Srl, H1 2016 26 Diarrhea - Pipeline by Ache Laboratorios Farmaceuticos S/A, H1 2016 27 Diarrhea - Pipeline by Actelion Ltd, H1 2016 28 Diarrhea - Pipeline by Aegis Therapeutics, LLC, H1 2016 29 Diarrhea - Pipeline by Akthelia Pharmaceuticals Limited, H1 2016 30 Diarrhea - Pipeline by AlbireoPharma, H1 2016 31 Diarrhea - Pipeline by Allergan Plc, H1 2016 32 Diarrhea - Pipeline by Anatara Lifesciences Limited, H1 2016 33 Diarrhea - Pipeline by Ardelyx, Inc., H1 2016 34 Diarrhea - Pipeline by Assembly Biosciences, Inc., H1 2016 35 Diarrhea - Pipeline by Chiesi Farmaceutici SpA, H1 2016 36 Diarrhea - Pipeline by Cosmo Pharmaceuticals S.p.A, H1 2016 37 Diarrhea - Pipeline by DesignMedix, Inc., H1 2016 38 Diarrhea - Pipeline by DiscoveryBiomed, Inc., H1 2016 39 Diarrhea - Pipeline by Genexine, Inc., H1 2016 40 Diarrhea - Pipeline by GlaxoSmithKline Plc, H1 2016 41 Diarrhea - Pipeline by GP Pharm, S.A., H1 2016 42 Diarrhea - Pipeline by Helsinn Healthcare S.A., H1 2016 43 Diarrhea - Pipeline by Intercept Pharmaceuticals, Inc., H1 2016 44 Diarrhea - Pipeline by Merck & Co., Inc., H1 2016 45 Diarrhea - Pipeline by Mucosis B.V., H1 2016 46 Diarrhea - Pipeline by Nippon Shinyaku Co., Ltd., H1 2016 47 Diarrhea - Pipeline by Novartis AG, H1 2016 48 Diarrhea - Pipeline by Pfizer Inc., H1 2016 49 Diarrhea - Pipeline by Prokarium Limited, H1 2016 50 Diarrhea - Pipeline by Protagonist Therapeutics Inc., H1 2016 51 Diarrhea - Pipeline by Rebiotix Inc., H1 2016 52 Diarrhea - Pipeline by RxBio, Inc., H1 2016 53 Diarrhea - Pipeline by Sanofi Pasteur SA, H1 2016 54 Diarrhea - Pipeline by Scandinavian Biopharma Holding AB, H1 2016 55 Diarrhea - Pipeline by Shire Plc, H1 2016 56 Diarrhea - Pipeline by Sigmoid Pharma Limited, H1 2016 57 Diarrhea - Pipeline by Summit Therapeutics Plc, H1 2016 58 Diarrhea - Pipeline by Synthetic Biologics, Inc., H1 2016 59 Diarrhea - Pipeline by Syntiron LLC, H1 2016 60 Assessment by Monotherapy Products, H1 2016 61 Number of Products by Stage and Target, H1 2016 63 Number of Products by Stage and Mechanism of Action, H1 2016 65 Number of Products by Stage and Route of Administration, H1 2016 67 Number of Products by Stage and Molecule Type, H1 2016 69 Diarrhea Therapeutics - Recent Pipeline Updates, H1 2016 140 Diarrhea - Dormant Projects, H1 2016 175 Diarrhea - Dormant Projects (Contd..1), H1 2016 176 Diarrhea - Dormant Projects (Contd..2), H1 2016 177 Diarrhea - Discontinued Products, H1 2016 178
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.